Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name prescription medicine

Tepadina

Generic name: Thiotepa

FDA application holder: Adienne Sa

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Tepadina?
Tepadina is a brand name of Thiotepa, a prescription medicine. The FDA NDC Directory lists 4 Tepadina products in 4 strengths and forms.
Who makes Tepadina?
Adienne Sa holds the FDA application for Tepadina (NDA208264, approved January 26, 2017).
Is there a generic or store brand of Tepadina?
Yes. The FDA NDC Directory lists 2 other products with the same active ingredients, strength and form as a Tepadina product, 2 of them generic. Ask your pharmacist whether one is right for you.
Has Tepadina been recalled?
No recall linked to Tepadina products (by their NDC code or label) appears in the FDA enforcement reports we use.

What Tepadina is

Each Tepadina product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Thiotepa · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
thiotepa 100 mg
injection, powder, for solution (intracavitary, intravenous, intravesical)
Tepadina 1 product, 1 company DailyMed
thiotepa 15 mg
injection, powder, for solution (intracavitary, intravenous, intravesical)
Tepadina 1 product, 1 company DailyMed
thiotepa 200 mg
injection, powder, lyophilized, for solution (intracavitary, intravenous, intravesical)
Tepadina None listed DailyMed
thiotepa 400 mg
injection, powder, lyophilized, for solution (intracavitary, intravenous, intravesical)
Tepadina None listed DailyMed

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Thiotepa →

FDA approval

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
FDA applications of Tepadina products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
NDA208264Adienne SaJanuary 26, 20174

Companies that list Tepadina

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Tepadina products.

Recalls

No recall linked to Tepadina products (by their NDC code or label) appears in the FDA enforcement reports.

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers